Healthcare ❯Pharmaceuticals

Diabetes Treatment

GLP-1 Receptor Agonists Mounjaro GLP-1 Agonists Semaglutide Weight Management Weight-loss Drug GLP-1 Drugs Januvia Obesity Management Injectable Drugs Ozempic Novo Nordisk Sales Performance Insulin Therapy Drug Pricing Type 2 Diabetes Clinical Trials

Study Investigates Vision Loss in Patients Using Popular Diabetes and Weight Loss Drugs

Eli Lilly Reports Mixed Q4 Results as Key Drug Sales Fall Short of Expectations

Eli Lilly Lowers 2024 Revenue Forecast as Weight-Loss Drug Sales Lag

Eli Lilly Announces $3 Billion Wisconsin Manufacturing Expansion

US Obesity Rates Projected to Surge by 2050

Senator Warren Urges FTC to Scrutinize Novo Holdings' $16.5B Catalent Acquisition

Alphabet Appoints Anat Ashkenazi as New CFO Amid AI Expansion

Youth Prescriptions for Weight Loss and Diabetes Drugs Surge Nearly 600%

Roche's Experimental Obesity Drug CT-388 Shows Significant Weight Loss in Early Trials

Eli Lilly's Weekly Insulin Matches Effectiveness of Daily Doses in Trials

U.S. Crude Oil Prices Surge Amid Supply Deficit Forecast and Geopolitical Tensions